Newsroom

[searchandfilter id="864"]
  • Press Release

    17 January 24

    CuraTeQ Biologics’ Trastuzumab Biosimilar receives recommendation for marketing authorization in India

    Read more
  • Press Release

    20 November 23

    CuraTeQ Biologics eyes ‘WuXi’ moment to kickstart Indian bio-CDMO sector

    Read more
  • Press Release

    10 July 23

    CuraTeQ Biologics to market Ustekinumab biosimilar to treat Crohn’s disease, arthritis

    Read more
  • Press Release

    05 July 23

    CuraTeQ Biologics announces positive Phase-3 results for Trastuzumab biosimilar

    Read more
  • Press Release

    12 January 22

    Aurobindo Pharma arm CuraTeQ expands scope of biosimilars distribution pact with Orion

    Aurobindo Pharma on Tuesday said its subsidiary CuraTeQ Biologics has expanded the scope…

    Read more
  • Press Release

    12 February 17

    Aurobindo Pharma forays into biosimilars development

    Aurobindo Pharma Limited is pleased to announce the acquisition of four cell culture derived biosimilar…

    Read more